The comparison of life compatibility between trisomy 2 and trisomy 21 (Down syndrome) by bioinformatic-based databases
Methods: The analyses included (i) the determination of total gene numbers and classifications, (ii) numbers and functions of housekeeping genes, tissue-specific genes, and imprinted gene numbers and (iii) comparing the profiles of the proteins involved in cell survival and cell death in both chromosomes.
Results: The results indicate that trisomy 2 is likely to be incompatible with life compared to trisomy 21 because both gene enrichment and function are important factors associated with the difference in survival rates. Protein-protein interaction analyses showed that the increased interaction rate in trisomy 2 leads to more complex pathological consequences due to disruptions in cellular functions, however the limited interaction network in trisomy 21 may help explain the clinical features of Down syndrome.
Conclusions: Compared to trisomy 2, the life compatibility of trisomy 21 is associated with gene numbers, functions, and protein-protein interactions.
1. Banzai M, Sato S, Matsuda H, Kanasugi H. Trisomy 1 in a case of a missed abortion. J Hum Genet. 2004;49(7):396-397. doi: 10.1007/s10038-004-0164-1.
2. Chen BF, Chan WY. The de novo DNA methyltransferase DNMT3A in development and cancer. Epigenetics. 2014;9(5):669-677. doi: 10.4161/epi.28324.
3. De Toma I, Sierra C, Dierssen M. Meta-analysis of transcriptomic data reveals clusters of consistently deregulated gene and disease ontologies in Down syndrome. PLoS Comput Biol. 2021;17(9):e1009317. doi: 10.1371/journal.pcbi.1009317.
4. Eisenberg E, Levanon EY. Human housekeeping genes are compact. Trends Genet. 2003;19(7):362-365. doi: 10.1016/S0168-9525(03)00140-9.
5. Eisenberg E, Levanon EY. Human housekeeping genes, revisited. Trends Genet. 2013;29(10):569-574. doi: 10.1016/j.tig.2013.05.010.
6. Gardiner K, Herault Y, Lott IT, Antonarakis SE, Reeves RH, Dierssen M. Down syndrome: from understanding the neurobiology to therapy. J Neurosci. 2010;30(45):14943-14945. doi: 10.1523/JNEUROSCI.3728-10.2010.
7. Hassold TJ, Jacobs PA. Trisomy in man. Annu Rev Genet. 1984;18:69-97. doi: 10.1146/annurev.ge.18.120184.000441.
8. White PS. Chromosome 1. In eLS, John Wiley & Sons, Ltd (Ed.). 2007. doi: 10.1002/9780470015902.a0005810.pub2.
9. Holmes G. Gastrointestinal disorders in Down syndrome. Gastroenterol Hepatol Bed Bench. 2014;7(1):6-8.
10. Schieve LA, Boulet SL, Boyle C, Rasmussen SA, Schendel D. Health of children 3 to 17 years of age with Down syndrome in the 1997-2005 national health interview survey. Pediatrics. 2009;123(2):e253-260. doi: 10.1542/peds.2008-1440.
11. Vilardell M, Rasche A, Thormann A, et al. Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes. BMC Genomics. 2011;12:229. doi: 10.1186/1471-2164-12-229.

Copyright (c) 2025 The European Research Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Downloads
Article Information
- Article Type Research Article
- Submitted February 21, 2026
- Published May 3, 2025
- Issue Vol. 11 No. 3 (2025)
- Section Research Article